drugset / Trial / NCT01693432
Docetaxel and S-1 for Advanced Esophageal Cancer
NaSingle-groupOpen-labelTreatment
Summary
This study will evaluate the efficacy of docetaxel and S-1 combination chemotherapy in Korean patients with esophageal cancer.
Timeline
- Start
- 2011-11
- Primary completion
- 2018-06
- Completion
- 2018-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Docetaxel | Small molecule | 60 mg/m2 | Intravenous |
| Subject | S-1 | Small molecule | 80 mg/m2 | Oral |